标题
Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis
作者
关键词
-
出版物
International Journal of Environmental Research and Public Health
Volume 17, Issue 10, Pages 3664
出版商
MDPI AG
发表日期
2020-05-25
DOI
10.3390/ijerph17103664
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Laboratory Parameters of Hemostasis, Adhesion Molecules, and Inflammation in Type 2 Diabetes Mellitus: Correlation with Glycemic Control
- (2020) Eleonora Palella et al. International Journal of Environmental Research and Public Health
- Basic and Clinical Pharmaco-Therapeutics of SGLT2 Inhibitors: A Contemporary Update
- (2020) Sanjay Kalra et al. Diabetes Therapy
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China
- (2020) Lei Pan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A hypothesis for pathobiology and treatment of COVID‐19 : The centrality of ACE1 / ACE2 imbalance
- (2020) Krishna Sriram et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- COVID-19 and diabetes: Can DPP4 inhibition play a role?
- (2020) Gianluca Iacobellis DIABETES RESEARCH AND CLINICAL PRACTICE
- SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons?
- (2020) Dario Pitocco et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications
- (2020) Daniel J Drucker ENDOCRINE REVIEWS
- Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis
- (2020) Ka Shing Cheung et al. GASTROENTEROLOGY
- Critical Illness in Patients With COVID-19
- (2020) Deborah J. Cook et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic
- (2020) Adam Brufsky JOURNAL OF MEDICAL VIROLOGY
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure
- (2020) Luca Spiezia et al. THROMBOSIS AND HAEMOSTASIS
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
- (2020) Cynthia Magro et al. Translational Research
- Prevalence and impact of diabetes among people infected with SARS-CoV-2
- (2020) G. P. Fadini et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Why are pregnant women susceptible to COVID-19? An immunological viewpoint
- (2020) Hong Liu et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Practical recommendations for the management of diabetes in patients with COVID-19
- (2020) Stefan R Bornstein et al. Lancet Diabetes & Endocrinology
- Coagulation abnormalities and thrombosis in patients with COVID-19
- (2020) Marcel Levi et al. Lancet Haematology
- Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
- (2019) Carolyn F. Deacon Frontiers in Endocrinology
- DPP‐4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population‐based cohort study
- (2019) Jong‐Mi Seong et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Glucagon-Like Peptide-1 Receptor Analogues in Type 2 Diabetes: Their Use and Differential Features
- (2019) Katherine A. Lyseng-Williamson CLINICAL DRUG INVESTIGATION
- The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect
- (2019) Konstantinos Makrilakis International Journal of Environmental Research and Public Health
- Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis
- (2019) Christian Hampp et al. DIABETES CARE
- Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes Mellitus
- (2019) Maria Mirabelli et al. Journal of Diabetes Research
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
- (2019) Maria Mirabelli et al. International Journal of Environmental Research and Public Health
- Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
- (2019) Marc Evans et al. Diabetes Therapy
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review
- (2018) Srinivasan Vedantham et al. Cells
- Overexpression of GLP-1 receptors suppresses proliferation and cytokine release by airway smooth muscle cells of patients with chronic obstructive pulmonary disease via activation of ABCA1
- (2017) Yan-Hong Sun et al. Molecular Medicine Reports
- Impact of DPP-4 inhibition on acute and chronic endothelial function in humans with type 2 diabetes on background metformin therapy
- (2017) Michael E Widlansky et al. VASCULAR MEDICINE
- Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials
- (2016) Karolin Bettge et al. DIABETES OBESITY & METABOLISM
- A dipeptidyl peptidase-4 inhibitor ameliorates hypertensive cardiac remodeling via angiotensin-II/sodium-proton pump exchanger-1 axis
- (2016) Haruya Kawase et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
- (2016) Young-Sun Lee et al. MEDIATORS OF INFLAMMATION
- The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management
- (2016) Ebenezer A. Nyenwe et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Perivascular Mast Cells Govern Shear Stress-Induced Arteriogenesis by Orchestrating Leukocyte Function
- (2016) Omary Chillo et al. Cell Reports
- Gliptin and GLP‐1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide‐induced endotoxemia
- (2015) Sebastian Steven et al. BASIC RESEARCH IN CARDIOLOGY
- Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors
- (2015) Julio Rosenstock et al. DIABETES CARE
- Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy
- (2015) Eusebio Chiefari et al. Diabetes Technology & Therapeutics
- DPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trials
- (2015) Wenjia Yang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats
- (2015) Marina Romaní-Pérez et al. ENDOCRINOLOGY
- Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies
- (2015) Zhengming Chen et al. LANCET
- DPP4 in diabetes
- (2015) Diana Röhrborn Frontiers in Immunology
- Modification of β-Defensin-2 by Dicarbonyls Methylglyoxal and Glyoxal Inhibits Antibacterial and Chemotactic Function In Vitro
- (2015) Janna G. Kiselar et al. PLoS One
- Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study
- (2014) Seoyoung C Kim et al. ANNALS OF THE RHEUMATIC DISEASES
- DPP4-directed therapeutic strategies for MERS-CoV
- (2014) Dirk Reinhold et al. LANCET INFECTIOUS DISEASES
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Dipeptidyl Peptidase‐4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow‐Mediated Vasodilatation in Type 2 Diabetic Patients
- (2013) Makoto Ayaori et al. Journal of the American Heart Association
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More